Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 08 November, 2019

BlackRock Group

Form 8.3 - Allergan PLC

RNS Number : 8393S
BlackRock Group
08 November 2019
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

BlackRock, Inc.

Company dealt in

Allergan plc

(Note 2)

US$0.0001 ordinary shares

Date of dealing

07 November 2019

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

21,003,514 (6.40%)

61,008 (0.01%)

(2) Derivatives (other than options)

3,938,741 (1.20%)

52,439 (0.01%)

(3) Options and agreements to purchase/sell

0 (0.00%)

0 (0.00%)

Total

24,942,255 (7.60%)

113,447 (0.03%)

             

 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

             

 

Ap20

 

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

Purchase

257

USD 178.2103

Purchase

7,443

USD 178.5332

Purchase

11,063

USD 178.6800

Purchase

5,140

USD 178.5729

Sale

274

USD 178.6800

   

Please note: there was also a Transfer Out of 15,502 Shares

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

CFD

Reducing Short

3,540

USD 178.5917

CFD

Reducing Short

593

USD 178.5937

CFD

Reducing Short

440

USD 178.6063

CFD

Reducing Short

4

USD 178.6800

   

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

(Note 5)

 

 

 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

   

 

Ap21

 

2.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any

relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to

which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

None

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                    NO

 

Date of disclosure

08 November 2019

Contact name

James Michael

Telephone number

+44 20 7743 3650

If

 

If a connected EFM, state nature of connection (Note 10)

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEEAAFPESENFFF

a d v e r t i s e m e n t